Protocol No: ECCT/24/06/04 Date of Protocol: 20-06-2024

Study Title:

Evaluating the Impact of Telemedicine on Postoperative Recovery in Cardiac Surgery Patients: A Multi-Center Prospective Study

Study Objectives:
  • Primary Objective:

    • To investigate the effect of canagliflozin on glycemic control, measured by changes in HbA1c levels, in patients with type 2 diabetes mellitus over a 24-week treatment period.
  • Secondary Objective:

    • To assess changes in body weight, blood pressure, and lipid profile in patients treated with canagliflozin.
    • To evaluate the safety and tolerability of canagliflozin in patients with type 2 diabetes mellitus.
    • To explore patient-reported outcomes related to quality of life and treatment satisfaction with canagliflozin therapy.
Laymans Summary:

This research looks at how using telemedicine (video calls with doctors) affects recovery after heart surgery. By studying patients from multiple hospitals, the researchers aim to see if virtual follow-ups can help patients heal better and faster compared to traditional in-person visits.

Abstract of Study:

This prospective multi-center study aims to evaluate the impact of telemedicine on postoperative recovery in patients who have undergone cardiac surgery. A total of 500 patients from five major hospitals will be enrolled and monitored for six months post-surgery. Participants will be divided into two groups: one receiving traditional in-person follow-up care, and the other receiving regular telemedicine consultations. Primary outcomes include readmission rates, complication rates, and patient satisfaction. Secondary outcomes focus on recovery time and healthcare costs. Initial findings indicate that telemedicine may enhance patient outcomes by providing timely medical advice and reducing the need for hospital visits. This study will contribute to understanding the role of telemedicine in improving postoperative care for cardiac surgery patients.